6821 — Asymchem Laboratories Tianjin Co Balance Sheet
0.000.00%
- HK$18.62bn
- HK$10.93bn
- CNY5.80bn
- 76
- 41
- 49
- 59
Annual balance sheet for Asymchem Laboratories Tianjin Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | CAS | CAS | CAS | CAS | CAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 2,122 | 6,633 | 7,423 | 9,007 | 7,522 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1,110 | 2,052 | 2,781 | 2,299 | 2,182 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 4,030 | 10,310 | 11,860 | 12,352 | 11,050 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 2,360 | 3,697 | 5,056 | 5,601 | 6,412 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 7,158 | 15,156 | 18,239 | 19,767 | 19,289 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 925 | 2,205 | 2,177 | 1,801 | 1,709 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 1,163 | 2,546 | 2,592 | 2,287 | 2,443 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 5,995 | 12,610 | 15,647 | 17,480 | 16,845 |
Total Liabilities & Shareholders' Equity | 7,158 | 15,156 | 18,239 | 19,767 | 19,289 |
Total Common Shares Outstanding |